Group One Trading
RLMD icon

Group One Trading’s Relmada Therapeutics RLMD Stock Holding History

Group One Trading’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38K Sell
200
-5,200
-96% -$36.3K ﹤0.01% 7111
2026
Q1 		$37.6K Buy
+5,400
New +$25.5K ﹤0.01% 5483
2025
Q1 		– Sell
-22,300
Closed -$11.6K – 8267
2024
Q4 		$11.6K Buy
22,300
+10,800
+94% +$26.3K ﹤0.01% 6026
2024
Q3 		$37.3K Sell
11,500
-6,000
-34% -$19.4K ﹤0.01% 4839
2024
Q2 		$52.5K Sell
17,500
-37,000
-68% -$134K ﹤0.01% 4499
2024
Q1 		$253K Sell
54,500
-129,700
-70% -$625K ﹤0.01% 3351
2023
Q4 		$763K Buy
184,200
+3,900
+2% +$11.5K ﹤0.01% 2710
2023
Q3 		$541K Sell
180,300
-200,200
-53% -$595K ﹤0.01% 2829
2023
Q2 		$936K Buy
380,500
+374,000
+5,754% +$1.03M ﹤0.01% 2419
2023
Q1 		$14.7K Sell
6,500
-104,400
-94% -$360K ﹤0.01% 5717
2022
Q4 		$387K Sell
110,900
-328,500
-75% -$2.89M ﹤0.01% 3276
2022
Q3 		$16.3M Buy
439,400
+410,300
+1,410% +$11.4M 0.03% 487
2022
Q2 		$553K Buy
29,100
+26,700
+1,113% +$582K ﹤0.01% 3321
2022
Q1 		$65K Buy
2,400
+2,000
+500% +$41.4K ﹤0.01% 5896
2021
Q4 		$9K Sell
400
-900
-69% -$20K ﹤0.01% 7415
2021
Q3 		$34K Buy
+1,300
New +$34.8K ﹤0.01% 6835
2020
Q2 		– Sell
-100
Closed -$3K – 6114
2020
Q1 		$3K Hold
100
– – ﹤0.01% 4904
2019
Q4 		$4K Buy
+100
New +$3.04K ﹤0.01% 4800

Other funds holding RLMD

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Group One Trading's RLMD Position: Q2 2026 in Review

Group One Trading sold out of Relmada Therapeutics (RLMD) in Q2 2026, closing a stake of 14,350 shares — an estimated $100K sold.

Group One Trading first reported a position in RLMD in Q1 2021 and held it in 16 quarters. The position peaked at $857K in Q1 2024. 126 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

  • Group One Trading reported no remaining Relmada Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 14,350 Relmada Therapeutics shares in Q2 2026, an estimated $100K.
  • Group One Trading first reported a position in Relmada Therapeutics in Q1 2021 and held it in 16 quarters.
  • Group One Trading's Relmada Therapeutics position peaked at $857K in Q1 2024.
  • 126 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.